Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Jonah ElliffDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA.ORCID 0000-0001-8129-2997
Hanora Van ErtDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA.ORCID 0000-0002-3259-1912
Kristina SevcikDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA.
Marija Anne DjurkovicHost Pathogens Interactions, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.ORCID 0009-0002-8449-146X
Danielle RuddDepartment of Biology, Mt. Mercy College, Cedar Rapids, IA 52402, USA.
Francoise GourroncDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA.ORCID 0009-0007-3885-2603
Aloysius KlingelhutzDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA.ORCID 0000-0003-4258-5046
Olena ShtankoHost Pathogens Interactions, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.ORCID 0000-0002-9848-8870
Wendy MauryDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA.ORCID 0000-0002-9892-4484
Funding
PREDOCTORAL TRAINING PROGRAM IN IMMUNOLOGYT32AI007485 · UNIVERSITY OF IOWA · 1995 to 2025
$1.2M
The role of macrophage podosomes in Ebola virus pathogenesisR21AI151717 · NIAID · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Olena Shtanko · 2022 to 2022
$248k
Tunneling nanotubes as an alternate route of Ebola virus disseminationR21AI154336 · NIAID · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Olena Shtanko · 2022 to 2022
$248k
Determining Tropism and Mechanisms of Ebola Virus Entry in Placental TissuesF30AI174686 · NIAID · UNIVERSITY OF IOWA · 2024 to 2025
$77k
Evaluating the impact of malaria on immunogenicity of the Ebola virus vaccineF30AI181340 · UNIVERSITY OF IOWA · 2025 to 2025
Antiviral AgentsEbolavirusHemorrhagic Fever, EbolaInterferonsKeratinocytesCell LineHumansVirus ReplicationAntiviral AgentsInterferonsantiviralEbola virusfilovirusinterferon-stimulated genekeratinocyteskintype III interferontype II interferontype I interferon
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Interferons Inhibit Ebola Virus Infection of Human Keratinocytes. · full record | Socratic